Progyny, Inc. Announces Details for Its First Quarter 2024 Results Report

Rhea-AI Summary

Progyny, Inc. will announce its financial results for the first quarter of 2024 on May 9, 2024. The company specializes in fertility, family building, and women's health benefits solutions. Interested participants can join the conference call to discuss the results.

NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, will report its financial results for the quarterly period ended March 31, 2024 after the close of the market on Thursday, May 9, 2024.

The company will host a conference call at 4:45 P.M. Eastern Time (1:45 P.M. Pacific Time) and issue a press release regarding its financial results prior to the start of the call.

Interested participants in the United States may access the conference call by dialing 1.866.825.7331 and using the passcode 265484. International participants may access the call by dialing 1.973.413.6106 and using the same passcode.

An audio replay of the call will be available through Thursday, May 16, 2024 and may be accessed by dialing 1.800.332.6854 (U.S. participants) or 1.973.528.0005 (international participants) with the passcode 265484.

A live webcast and archive of the call will be available from the Events and Presentations section of the Company’s website at http://investors.progyny.com.

About Progyny
Progyny (Nasdaq: PGNY) is a transformative fertility, family building and women’s health benefits solution, trusted by the nation’s leading employers, health plans and benefit purchasers. We envision a world where everyone can realize their dreams of family and ideal health. Our outcomes prove that comprehensive, inclusive and intentionally designed solutions simultaneously benefit employers, patients and physicians. 

Our benefits solution empowers patients with concierge support, coaching, education, and digital tools; provides access to a premier network of fertility and women's health specialists who use the latest science and technologies; drives optimal clinical outcomes; and reduces healthcare costs. 

Headquartered in New York City, Progyny has been recognized for its leadership and growth by CNBC Disruptor 50, Modern Healthcare’s Best Places to Work in Healthcare, Forbes’ Best Employers, Financial Times, Inc. 5000, Inc. Power Partners, and Crain’s Fast 50 for NYC. For more information, visit www.progyny.com. 

For Further Information, Please Contact:
Investors:
James Hart
investors@progyny.com

Media:
Selena Yang
media@progyny.com

FAQ

When will Progyny, Inc. announce its financial results for the first quarter of 2024?

Progyny, Inc. will report its financial results for the quarterly period ended March 31, 2024 after the close of the market on Thursday, May 9, 2024.

What does Progyny, Inc. specialize in?

Progyny, Inc. specializes in transformative fertility, family building, and women's health benefits solutions.

How can participants access the conference call to discuss Progyny's financial results?

Interested participants in the United States may access the conference call by dialing 1.866.825.7331 with the passcode 265484. International participants can dial 1.973.413.6106 with the same passcode.

Where can participants find the audio replay of the conference call?

An audio replay of the call will be available through Thursday, May 16, 2024, by dialing 1.800.332.6854 (U.S. participants) or 1.973.528.0005 (international participants) with the passcode 265484.

Is there a live webcast and archive of the call available?

Yes, a live webcast and archive of the call will be available from the Events and Presentations section of the Company’s website at http://investors.progyny.com.